Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis.
Evaluation of Low-dose Albumin and Midodrine Versus Midodrine Alone in Outcome of Recurrent Ascites in Patients With Decompensated Cirrhosis - An Open Label Multicentric Randomized Controlled Trial.
Sponsor: Institute of Liver and Biliary Sciences, India
A NA clinical study on Decompensated Cirrhosis, this trial is ongoing. The trial is conducted by Institute of Liver and Biliary Sciences, India and has accumulated 5 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Unknown NA
-
Jul 2025 — Sep 2025 [monthly]
Unknown NA
Status: Not Yet Recruiting → Unknown
-
Sep 2024 — Jul 2025 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Mar 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
First recorded
Feb 2024
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institute of Liver and Biliary Sciences, India
For direct contact, visit the study record on ClinicalTrials.gov .